Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area.

by Daniel P O'Brien, N Deborah Friedman, Anthony McDonald, Peter Callan, Andrew Hughes, Eugene Athan
Published 2014-01-01

Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.

by Daniel P O'Brien, N Deborah Friedman, Anthony McDonald, Peter Callan, Andrew Hughes, Aaron Walton, Eugene Athan
Published 2018-03-01

Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.

by Daniel P O'Brien, N Deborah Friedman, Raquel Cowan, James Pollard, Anthony McDonald, Peter Callan, Andrew Hughes, Eugene Athan
Published 2015-12-01

Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.

by N Deborah Friedman, Eugene Athan, Andrew J Hughes, Masoomeh Khajehnoori, Anthony McDonald, Peter Callan, Richard Rahdon, Daniel P O'Brien
Published 2013-01-01

Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?

by Raquel Cowan, Eugene Athan, N Deborah Friedman, Andrew J Hughes, Anthony McDonald, Peter Callan, Janet Fyfe, Daniel P O'Brien
Published 2015-02-01

Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.

by Daniel P O'Brien, Anthony McDonald, Peter Callan, Mike Robson, N Deborah Friedman, Andrew Hughes, Ian Holten, Aaron Walton, Eugene Athan
Published 2012-01-01